IRIS
CASOLI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.354
EU - Europa 1.014
AS - Asia 618
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
OC - Oceania 2
Totale 2.997
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.309
CN - Cina 400
UA - Ucraina 227
IE - Irlanda 216
SE - Svezia 197
SG - Singapore 178
FI - Finlandia 141
DE - Germania 105
CA - Canada 44
FR - Francia 39
TR - Turchia 38
GB - Regno Unito 37
IT - Italia 30
BE - Belgio 14
EU - Europa 5
CI - Costa d'Avorio 3
AT - Austria 2
IN - India 2
NO - Norvegia 2
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
HR - Croazia 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
Totale 2.997
Salva come PNG Salva come JPEG
Città #
Jacksonville 232
Dublin 216
Chandler 204
Singapore 144
Beijing 108
Dearborn 95
Ann Arbor 82
Boardman 74
Nanjing 69
Ashburn 58
Princeton 48
San Mateo 48
Shanghai 46
Toronto 38
Izmir 37
Wilmington 34
Shenyang 22
Hebei 20
Woodbridge 20
Kunming 19
Los Angeles 18
Seattle 18
Hefei 17
Nanchang 16
Brussels 14
Jinan 14
Helsinki 12
New York 10
Tianjin 10
Changsha 9
Jiaxing 9
Norwalk 8
Auburn Hills 7
Guangzhou 6
Parma 6
Santa Clara 6
Bremen 5
Hangzhou 4
Rockville 4
Taiyuan 4
Abidjan 3
Dallas 3
Houston 3
Rome 3
Xian 3
Centuripe 2
Des Moines 2
Düsseldorf 2
Isorella 2
London 2
Montréal 2
Ningbo 2
Oslo 2
Pune 2
Redwood City 2
Vienna 2
Zhengzhou 2
Bibbiano 1
Brno 1
Catania 1
Chengdu 1
Chongqing 1
Corner Brook 1
Edinburgh 1
Forest City 1
Fremont 1
Fuzhou 1
Kocaeli 1
Mantova 1
Meda 1
Monmouth Junction 1
Munich 1
Nuremberg 1
Odesa 1
Ottawa 1
Padova 1
Palma De Mallorca 1
Quzhou 1
Redmond 1
Stockholm 1
Swift Current 1
Sydney 1
Wellington 1
Zagreb 1
Totale 1.877
Salva come PNG Salva come JPEG
Nome #
Biological insight into the mechanism of action of thiosemicarbazone complexes. 124
Copper(II) and Cobalt(III) Pyridoxal Thiosemicarbazone Complexes with Nitroprusside as Counterion: Syntheses, Electronic Properties, and Antileukemic Activity 109
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 99
Striking changes of miRNAs expression in CD4+ T lymphocytes occurred even in the absence of an established HIV-1 infection. 84
THIOSEMICARBAZONES DERIVATIVES (TSCD) EFFECTS ON HIV, HTLV-1 AND HTLV-2 INFECTED CELLS 84
Exposure of TF-1 cells to HTLV-II induces the activation of STAT1 and STAT5 through the secretion of IFN-g and GM-CSF 79
HTLV-II influence on AIDS progression and changes in response to antiretroviral therapy in Italian IDUs coinfected with HIV-1 76
Antiretroviral Activity of Thiosemicarbazone Metal Complexes 76
HTLV-II infection exerts a protective role against AIDS progression in IDUs coinfected with HIV-1 76
Screening of HIV-1 Isolates By Reverse Heteroduplex Mobility Assay and Identification of Non-B Subtypes in Italy 72
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 72
HIV e riproduzione umana 70
HTLV-II Downregulates HIV-1 replication in IL-2 Stimulated PBMC Cultures of Co-infected Individuals Through Expression of MIP-1a 70
Anti-CD4-gp120 complex antibodies in long-term non-progressors HIV-1 positive patients: a role in slowing disease progression? 67
Expression of cytokines and of chemokine receptors in PBMCs of HTLV-II mono-infected and HTLV-II/HIV-1 co-infected individuals 65
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 65
Azione concertata ELVIS: espressione selettiva della chemochina CCL3L1 in soggetti LTNP co-infettati da HIV-1 e HTLV-2 64
La coinfezione HIV-1/HTLV-II è associata ad un rallentamento della progressione AIDS 63
Un mimotopo sintetico killer, attivo nei confronti di patogeni opportunisti correlati ad AIDS inibisce l’infezione esogena ed endogena di HIV 63
Epidemiological and molecular data on 170 HTLV-2 cases of Italian IDUs 62
Delayed progression to aids in HTLV-2/HIV-1 coinfected intravenous drug users 60
HTLV-II Replication inversely correlates with the expression of CIITA, the major regulator of HLA class II transcription 59
Negative interference of HTLV-II on HIV-1 replication via CC chemokines 59
Human T-cell Leukemia virus type II (HTLV-II) induces STAT1 and STAT5 activation in CD34+ TF-1 cells 59
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of CCL3L1 59
Up-regulation of the LD78b isoform of MIP-1a in PBMC cultures obtained from HTLV-2 infected/HIV-1 exposed seronegative individuals 59
HTLV-2 induces resistance to CCR5-dependent HIV-1 infection via selective PBMC expression of the CCL3/MIP-1alpha isoform L1/LD78beta 58
Human T-cell leukemia virus type II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of Interferon-g and Granulocyte Macrophage-Colony Stimulating Facto 58
PBMC expression of cytokines and chemokine receptors in relation to AIDS progression and HTLV-II co-infection 57
A dual defensive role of CIITA against retroviral infections 56
Retroviral cross-talk: HTLV-II Downregulates HIV-1 Replication from PBMC Cultures of Co-infected Individuals Via MIP-1a 56
Selective CCL3L1/LD78b production by PBMCs during HTLV-2 infection induces resistance to HIV-1 entry 55
HTLV-2 influence on pathways regulating proliferation and death in B cell line BJAB 55
Serological and clinical follow-up of an Italian IVDU cohort of HTLV-II/HIV-1 co-infected patients. Evidence of direct relationship between CD4 count and HTLV-II proviral load 53
Specificity of the reverse Heteroduplex Mobility Assay (rHMA) for the identification of HIV-1 non-B clades in the new AIDS epidemic in Italy sustained by sexual transmission 53
Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures 52
The origin and evolution of Human T-cell Lymphotropic virus type II (HTLV-II) and the relationship with its replication 51
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 51
Anti-CD4-GP120 complex antibodies in long term non progressors HIV-1 positive patients: a role in slowing disease progression?  51
The MHC class II transactivator: prey and hunter in infectious diseases 50
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 50
Post-genomic upregulation of CCL3L1 expression in HTLV-2 infected individuals curtails HIV-1 replication 47
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 47
Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells 45
HTLV-II induces survival and proliferation of CD34+ TF-1 cells via activation of STAT1 and STAT5 by secretion of IFN-g and GM-CSF 44
The MHC Class II Transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection 43
Inibizione della replicazione virale di HIV-1 e HTLV-2 da parte di CIITA, il regolatore trascrizionale dell’espressione dell’HLA-II 42
Inhibition of human T cell leucemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y 37
Totale 3.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020414 0 0 0 0 64 82 80 9 57 50 21 51
2020/2021388 6 55 51 3 55 4 48 4 91 11 56 4
2021/2022250 3 8 1 9 18 1 35 48 7 19 45 56
2022/2023786 92 96 51 63 66 70 12 37 262 4 22 11
2023/2024252 22 33 2 4 28 49 18 23 12 6 13 42
2024/2025229 4 56 59 52 58 0 0 0 0 0 0 0
Totale 3.006